Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-21FDA Approved: QULIPTA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for QULIPTA (atogepant) submitted by AbbVie.
-
FDA approval · 2025-03-21FDA Approved: UBRELVY — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Ubrelvy (ubrogepant) from Allergan, Inc.
-
FDA label_change · 2025-03-21FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for Aimovig (erenumab-aooe) submitted by Amgen. The approval updates the product labeling per the su…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
A clinical trial update notes a specified drug-use survey evaluating long-term subcutaneous AJOVY (fremanezumab) use for migraine, currently…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine
A clinical trial update reports that Atogepant is being studied for episodic migraine and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-17FDA Approved: SUMATRIPTAN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Rising Pharma Holdings' Sumatriptan generic product under an ANDA. This marks an update to t…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine [Phase 3]
Phase 3 study evaluating oral atogepant for episodic migraine in adult Japanese participants has completed.
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Can a Specific OMT Protocol Influence Patient Pain and Associated Analgesia Use for Primary Headache Disorders? [NA]
This clinical trial update notes a prospective study by the New York Institute of Technology to evaluate whether an osteopathic manipulative…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Investigation of the Effect of Cold Application in Migraine [NA]
A completed clinical trial evaluated the effect of cold application on migraine. The study context also mentions relaxation and exercise as …
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Migraine Research with Smartwatch Application
A migraine-related clinical trial in Germany (Heinrich-Heine University) using a smartwatch app is currently active but not recruiting.
-
FDA approval · 2025-03-12FDA Approved: TOPIRAMATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Topiramate from Upsher-Smith Laboratories, LLC. The document indicates an approval action relate…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents [Phase 3]
Phase 3 pilot trial evaluating an investigational neuromodulation device for acute migraine attacks in children and adolescents has complete…
-
FDA approval · 2025-03-12FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for TOPAMAX (topiramate) filed by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine [Phase 3]
Phase 3 trial comparing PFO closure with medical therapy for migraine, focusing on effectiveness and safety; the study is currently active b…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants [Phase 1]
Vaxxinity reports Phase 1 results assessing the safety, tolerability, and immunogenicity of UB-313 in healthy participants for migraine.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: The Effect of a Video-Based Exercise Program on Migraine Symptoms [NA]
This clinical trial update reports a study evaluating the impact of a video-based exercise program on migraine symptoms. Enrollment is by in…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Craniocervical Flexion Training for Reducing Migraine Headaches and Disability [NA]
This clinical trial update reports the completion of a study evaluating craniocervical flexion training for reducing migraine headaches and …
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study
A real-world evidence study evaluating the combination of sumatriptan and naproxen for acute treatment of migraine; the study is not yet rec…
-
FDA approval · 2025-03-10FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TROKENDI XR (topiramate) submitted by Supernus Pharmaceuticals, Inc. The approval updates th…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: The Effect of Different Exercise Types on Migraine Frequency in Individuals With Migraine [NA]
A completed clinical trial from Ege University evaluated how different exercise types affect migraine frequency in individuals with migraine…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Migraine and Neuropathic Pain in Osteoarthritis
This clinical trial update notes a study investigating migraine and neuropathic pain in patients with osteoarthritis. The trial is currently…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Muscle Function and Tenderness Differences in Headache Patients
A Danish Headache Center-led clinical trial update investigates differences in muscle function and tenderness among patients with migraine, …
-
FDA approval · 2025-03-07FDA Approved: ALMOTRIPTAN — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for ALMOTRIPTAN (almotriptan) from Ajanta Pharma USA Inc., signaling an update to the product's …
-
FDA approval · 2025-02-26FDA Approved: TOPIRAMATE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Topiramate by Ascend Laboratories, LLC (ANDA 217795), resulting in an updated regulatory action …
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine [EARLY_Phase 1]
Phase 1 study evaluating the safety and effectiveness of embolization of the middle meningeal artery using SQUID 12 and SQUID 18 for chronic…